On this Friday afternoon, we thought we’d let our readers know about a couple of other drug/device-related irons that members of your blogging team have in the fire right now.
First, as you know, we’ve been interested in the innovative potential of 3D printing – particularly of medical devices, but drugs, too. Our posts on the potentially disruptive effects of 3D printing on traditional product liability categories are available here.
Second, the Dechert side of the blog – Michelle Yeary – is co-chairing a conference called “Drug and Device Defense − Emerging Litigation & Regulatory Developments.” Also participating is as well a former Dechert blogger Will Sachse. Unlike the blog, this conference is only open to the folks on our side, being billed as a “defense-only conference on drug and device litigation and regulation.” That means the presenters will be able to discuss things that we don’t talk about on the blog because we don’t want to give the other side any bright ideas.
The topics at Michelle’s conference include: (1) The relationship between in-house and outside counsel; (2) Developments relating to labeling and promotion of brands and generics; (3) Best practices in handling government investigations; (4) State of mass tort litigation today; (5) Matters to watch in 2016 and beyond; (6) Emerging issues such as 3D printing of medical devices; and (7) Ethical issues for lawyers in litigation.
The conference will occur on October 20, 2015, all day from 8:30 through 5:30, at the Hub Cira Center in Philadelphia at 2929 Arch St. − that’s the shiny glass building behind the 30th Street train station.